Fast Market Research announces the availability of the new TechNavio report,"Global Prostate Cancer Drugs Market 2016-2020", on their comprehensive research portal

Boston, MA -- (SBWire) -- 01/17/2017 --Prostate cancer is the cancer of prostate gland. According to CDC, it is one of the leading cause of cancer death in men across the races in the US. According to the Urology Care Foundation, globally, one in seven men will be diagnosed with the disease. About one in 35 men die due to prostate cancer. Growth in the prostate can be benign or malignant. Prostate cancer cells spread by breaking away from a prostate tumor. They may travel through blood vessels or lymph vessels and reach other parts of the body. The cells that spread might bind to other tissues, form new tumors, and sometimes damage those tissues as well. When prostate cancer cells spread from their original place to another, the new tumor formed also has the same kind of abnormal cells.

Technavio's analysts forecast the global prostate cancer drugs market to grow at a CAGR of 9.21% during the period 2016-2020.

Get More Details on this Report and a Full Table of Contents at Global Prostate Cancer Drugs Market 2016-2020

Covered in this report
The report covers the present scenario and the growth prospects of the global prostate cancer drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Prostate Cancer Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AbbVie
-Astellas Pharma
-AstraZeneca
-Johnson & Johnson
-Sanofi

Other prominent vendors

-Active Biotech
-ADC Therapeutics
-Advantagene
-Advaxis Pharmaceuticals
-ANI Pharmaceuticals
-ArQule
-Athenex Pharmaceuticals
-Bavarian Nordic
-Bayer HealthCare
-BHR Pharma
-BMS
-Boehringer Ingelheim
-Camurus
-Cleveland BioLabs
-CureVac
-Dendreon
-Dextech Medical
-Eisai
-Endo Pharmaceuticals
-Ferring Pharmaceutical
-Foresee Pharmaceuticals
-GlaxoSmithKline
-GTx
-Innocrin Pharmaceutical
-Inspyr Therapeutics
-Io Therapeutics
-Lidds AB
-Merck Group
-Myovant Sciences
-Northwest Biotherapeutics
-Novartis
-Nymox Pharmaceuticals
-OncoGenex
-Oncolytics Biotech
-Orion
-Pharmamar
-Progenics Pharmaceuticals
-Sotio
-Spectrum Pharmaceuticals
-Synta
-Takeda Pharmaceuticals
-Teva Pharmaceutical
-Tokai Pharmaceuticals

Market driver

-Physicians preference toward adopting hormonal therapies
-For a full, detailed list, view our report

Market challenge

-Presence of alternative treatment approaches
-For a full, detailed list, view our report

Market trend

-Emergence of targeted therapies and immunotherapies
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AbbVie, Astellas Pharma, AstraZeneca, Johnson & Johnson, Sanofi, Active Biotech, ADC Therapeutics, Advantagene, Advaxis Pharmaceuticals, ANI Pharmaceuticals, ArQule, Athenex Pharmaceuticals, Bavarian Nordic, Bayer HealthCare, BHR Pharma, BMS, Boehringer Ingelheim, Camurus, Cleveland BioLabs, CureVac, Dendreon, Dextech Medical, Eisai, Endo Pharmaceuticals, Ferring Pharmaceutical, Foresee Pharmaceuticals, GlaxoSmithKline, GTx, Innocrin Pharmaceutical, Inspyr Therapeutics, Io Therapeutics, Lidds AB, Merck Group, Myovant Sciences, Northwest Biotherapeutics, Novartis, Nymox Pharmaceuticals, OncoGenex, Oncolytics Biotech, Orion, Pharmamar, Progenics Pharmaceuticals, Sotio, Spectrum Pharmaceuticals, Synta, Takeda Pharmaceuticals, Teva Pharmaceutical, Tokai Pharmaceuticals

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016
-Metastatic Prostate Cancer Global Clinical Trials Review, H2, 2016
-Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016
-Global Solid Tumors Drugs Market 2016-2020
-Global Gastric Cancer Drugs Market 2016-2020